Rectal cancer: Treatment - Health Professional Information [NCI PDQ] - Quest Diagnostics Patient Health Library Rectal cancer: Treatment - Health Professional Information [NCI PDQ] This information is produced and provided by the National Cancer Institute (NCI).
Ovarian epithelial cancer: Treatment - Health Professional Information [NCI PDQ] - Quest Diagnostics Patient Health Library Ovarian epithelial cancer: Treatment - Health Professional Information [NCI PDQ] This information is produced and provided by the National Cancer Institute (NCI).
Capecitabine - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Capecitabine - [Medication] - Quest Diagnostics Patient Health Library Capecitabine - [Medication] - Quest Diagnostics Patient Health Library Cancer, antineoplastic agents, antineoplastic chemotherapy, Cancer Chemotherapy, Chemotherapy,...
http://www.fda.gov/cder/orange/appendix_a.txt 4, ACETAMINOPHEN TYLENOL W/ CODEINE, ACETAMINOPHEN TYLENOL, ACETAMINOPHEN (OTC) TYLOX, ACETAMINOPHEN TYLOX-325, ACETAMINOPHEN TYMTRAN, CERULETIDE DIETHYLAMINE TYZINE, TETRAHYDROZOLINE HYDROCHLORIDE TZ-3, TIOCONAZOLE (OTC) ** U ** U-CORT, HYDROCORTISONE ACETATE U-GENCIN, GENTAMICIN SULFATE UCEPHAN, SODIUM BENZOATE ULO, CHLOPHEDIANOL HYDROCHLORIDE ULTANE, SEVOFLURANE ULTIVA,...
1998 Warning Letters and Untitled Letters to Pharmaceutical Companies DDMAC 6/25 6/29 Maxipime (Cefepime HCl) for Injection Bristol-Myers Squibb DDMAC 6/29 8/3 Mircette (Desogestrel/Ethinyl Estradiol and Ethinyl Estradiol) Tablets Organon DDMAC 6/1 6/9 Naprelan (Naproxen Sodium) Tablets Wyeth-Ayerst DDMAC 6/8 6/29 Nasacort (Triamcinolone Acetonide) Rhone-Poulenc Rorer DDMAC 6/25 6/29 Nasonex (mometasone furoate monohydrate) nasal spray Schering...
20896s6_Xeloda (Capecitabine) Tablets Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Xeloda (Capecitabine) Tablets Company:--Roche Pharmaceuticals Application No.:--20-896/S006 & S009 Approval Date:-4/30/01 - Approval(ble) Letter(s) - Medical Review(s)/Statistical Review Part 1 - Part 2 - Chemistry Review(s) - Pharmacology Review(s) - Statistical Review(s) ...
author: Paul Stauffer
Drug Approvals - X Product Name Company Application # Approval Date Letter Posted Label Posted Review Posted Xalatan (latanoprost) ophthalmic solution, 0.005%,- Pharmacia & Upjohn Company NDA 20-597/S28 & S29 7/14/03 7/28/03 Xalatan (latanoprost) ophthalmic solution, 0.005%,- Pharmacia & Upjohn Company NDA 20-597/S-025 8/26/02 8/30/02 8/26/02 Xalatan (latanoprost) ophthalmic solution, 0.005%,-...
Cancer.gov - Rectal Cancer (PDQ®): Treatment Rectal Cancer (PDQ®): Treatment Two versions of this document are available
Cancer.gov - Colon Cancer (PDQ®): Treatment J Clin Oncol 16 (11): 3537-41, 1998.A- [PUBMED Abstract] Twelves C, Boyer M, Findlay M, et al.: Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma
News Releases 2003 For more information about the risks and uncertainties, contact the Public Relations Office 2003 In order to view the PDF files, you will need to download the Acrobat Reader - [Dec, 2003] Relocation of the West Japan Distribution Center(Chugai Distribution Co., Ltd.) (Dec 3, 2003) - [Nov, 2003] 2003 Voluntary Recall of anti-influenza drug Tamiflu® Dry Syrup 3%, Cap-Opened...
An Increasing Number of Treatments Has Added Therapeutic Complexity An Increasing Number of Treatments Has Added Therapeutic Complexity 0 1 2 3 4 5 6 7 1960 1965 1970 1975 1980 1985 1990 1995 2000 2005 Year Drugs Available Cituximab (Erbitux)* Bevacizumab (Avastin)* Oxaliplatin (Eloxatin) Capecitabine (Xeloda) Irinotecan/CPT-11 (Camptosar) Leucovorin (Leucovorin) 5-fluorouracil (Adrucil) *Not yet FDA approved Previous slide Next slide...
CDER Report to the Nation: 2001 Food and Drug Administration • Center for Drug Evaluation and Research About CDER - Report Search CDER Report to the Nation: 2001 Table of Contents 1 Drug Review Index Mission Highlights New Drug Review Standard new drugs Priority new drugs New molecular entities Standard NMEs Priority NMEs Orphan drug approvals Notable 2001 new drug approvals New or Expanded Use Review...
author: OLIVERN
NDAs Approved under Subpart H NDAs Approved under Subpart H NDA # Trade Name Generic -Name Clock Date Approval Date AP Time Approval Basis Indication - - - - - - - - 20199 Hivid Zalcitabine 31-Oct-91 19-Jun-92 7.6 S Combination therapy with zidovudine in advanced HIV infection - - - - - - - - 50698 Biaxin Clarithromycin- 2-Nov-92 23-Dec-93 13.7 S Treatment of disseminated mycobacterial infections due to...
author: Darlene Norris
application notes - OraChrom, Inc
Appl. Note 25 - OraChrom, IncXELODA (Capecitabine) in Urine Sample with STYROS ™ 2R/XHXELODA or Capecitabine is a drug with antineoplastic activity
Facts & News - OraChrom, Inc
FDA Drug Approvals List September 2001 - Drug Approvals for September 2001 Definitions and Notes Original New Drug Applications Original Application #: 021279 Approval Date: 25-SEP-01 Trade Name: FORADIL Chemical Type: 3 Therapeutic Potential: S Dosage Form: POWDER, FOR INHALATION Applicant: NOVARTIS PHARMACEUTICALS CORP Active Ingredient(s): FORMOTEROL FUMARATE OTC/RX Status: RX Indication(s): For the long-term, twice...
FDA Drug Approvals List April 2001 - Drug Approvals for April 2001 Definitions and Notes Original New Drug Applications Original Application #: 020949 Approval Date: 30-APR-01 Trade Name: ACCUNEB Chemical Type: 5 Therapeutic Potential: S Dosage Form: SOLUTION Applicant: DEY LABORATORIES INC Active Ingredient(s): ALBUTEROL SULFATE OTC/RX Status: RX Indication(s): For the treatment of asthma-related bronchospasm in...
FDA Drug Approvals List March 2001 Original Application #: 021082 Approval Date: 01-MAR-01 Trade Name: TAVIST ALLERGY/SINUS/HEADACHE Chemical Type: 4 Therapeutic Potential: S Dosage Form: TABLET Applicant: NOVARTIS CONSUMER HEALTH INC Active Ingredient(s): ACETAMINOPHEN; CLEMASTINE FUMARATE; PSEUDOEPHEDRINE HYDROCHLORIDE OTC/RX Status: OTC Indication(s): For temporary relief of symptoms associated with hay fever,...
Microsoft Word - e_Xeloda_f2.doc page 1
author: B00078
http://www.chugai-pharm.co.jp/html/meeting/pdf/020130_1_booklet.pdf rjapanj\ Investor Relations\ 020129\ NR_ booklet_ 020129_ 4
duplicates:http://www.chugai-pharm.co.jp/html/meeting/pdf/020130e_1_booklet.pdf
http://www.chugai-pharm.co.jp/html/meeting/pdf/020130_1_booklet.pdf page 20
duplicates:http://www.chugai-pharm.co.jp/html/meeting/pdf/020130e_1_booklet.pdf
xeloda capecitabine Capecitabine has the following structural for ula: O OH H 3 C HO O O N N O NH F Capecitabine is a white to off- white crystalline powder with an aqueous solubility of 26 g/ L at 20º CCapecitabine is readily absorbed fro gastrointestinal tractCapecitabine reached peak blood levels...
subject: package insert labeling
xeloda capecitabine page 18
subject: package insert labeling
xeloda capecitabine page 16
subject: package insert labeling
